No Data
No Data
Enliven Therapeutics(ELVN.US) Director Sells US$30,149.67 in Common Stock
$Enliven Therapeutics(ELVN.US)$ Director Heyman Richard A. sold 1,270 shares of common stock on May 16, 2024 at an average price of $23.7399 for a total value of $30,149.67.Source: Announcement What i
Enliven Therapeutics Insider Sold Shares Worth $22,877,262, According to a Recent SEC Filing
Rishi Gupta, 10% Owner, Director, on May 16, 2024, sold 1,033,300 shares in Enliven Therapeutics (ELVN) for $22,877,262. Following the Form 4 filing with the SEC, Gupta has control over a total of 7,6
Form 144 | Enliven Therapeutics(ELVN.US) Director Proposes to Sell 121.77K in Common Stocks
SEC FILLINGS DISCLOSED/ May 17, $Enliven Therapeutics(ELVN.US)$ Director The Biotech Growth Trust PLC intends to sell 5,500 shares of its common stock on May 16, with a total market value of approxima
Form 144 | Enliven Therapeutics(ELVN.US) Director Proposes to Sell 22.14 Million in Common Stocks
SEC FILLINGS DISCLOSED/ May 17, $Enliven Therapeutics(ELVN.US)$ Director OrbiMed Private Investments VII, LP intends to sell 1 million shares of its common stock on May 16, with a total market value o
Form 144 | Enliven Therapeutics(ELVN.US) Director Proposes to Sell 737.26K in Common Stocks
SEC FILLINGS DISCLOSED/ May 17, $Enliven Therapeutics(ELVN.US)$ Director OrbiMed Genesis Master Fund, L.P. intends to sell 33,300 shares of its common stock on May 16, with a total market value of app
Enliven Therapeutics(ELVN.US) Officer Sells US$27,675 in Common Stock
$Enliven Therapeutics(ELVN.US)$ Officer Patel Anish sold 1,107 shares of common stock on May 14, 2024 at an average price of $25 for a total value of $27,675.Source: Announcement What is statement of
No Data